Law360, New York (January 20, 2012, 8:37 PM ET) -- Attorneys from Covington & Burling LLP’s life sciences group helped Eli Lilly & Co. unravel a long-standing marketing partnership with Amylin Pharmaceuticals Inc. in an arrangement that could net Eli Lilly some $1.6 billion, one of several victories that earned the firm a spot among Law360’s Health Groups of 2011.
Eli Lilly and Amylin had entered into a joint marketing agreement in 2002 to bring the Type 2 diabetes drug exenatide to market. They rolled out the brand name drug Byetta in 2005, and were planning...
Health Group Of The Year: Covington & Burling
To view the full article, take a free trial now.
